₹2954.0
+0.33% today
· 30d +14.5%
as of 2026-09-04
Price · Daily Candles
“Glaxo slips near 52-week low as FIIs reduce stake, growth outlook dims.”
Glaxo (INE159A01016) has seen its share price fall 18.11% over the last year, now trading just 2.9% above its 52-week low of ₹2217.6. The company reported modest YoY revenue growth for Q4 2026 at 2.15% and an annual 1.93%. Despite this and a strong profitability score of 95, Machine Learning models predict weak Free Cash Flow growth, with a rank of 0.057 for 4-year rolling and 0.099 for 7-year stable FCF.
BULL CASE
+Glaxo's annual net profit grew by 11.69% YoY to ₹1036 Cr in FY2026.
+The company boasts a high profitability score of 95 and a ROCE of 65.0%.
+Quarterly net profit rose 5.7% YoY to ₹278 Cr for Q4 2026.
+Glaxo's 5-year Net Profit CAGR stands at an impressive 23.67%.
BEAR CASE
−The stock is trading 35.09% off its 52-week high of ₹3515.7 and is near its 52-week low.
−FII shareholding decreased by 0.02 percentage points QoQ, from 4.64% to 4.62% in Q4 2026.
−Its 1-year returns are negative 18.11%, underperforming the market.
−Machine Learning predictions indicate weak FCF growth, with a 4-year rolling rank of 0.057 and 7-year stable rank of 0.099.
⟳ What Changed
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹938 Cr
+16.55% YoY
NET PROFIT
₹237 Cr
+15.69% YoY
OPM
34.54%
-0.2pp YoY
EPS
₹14.0
PE 38.02
Intrinsic value · DCF ₹1122.83 · Margin of safety -62.0% (overvalued) · FCF yield 1.69%
◇ Sector Position
Glaxo's PE of 38.02 is higher than Marksans Pharma (30.34) but lower than Sanofi India (44.71), while its ROCE of 65.0% is strong compared to Pfizer (25.0%) but below Sanofi India's 84.87%.
PEERPEROCE %
GLAXO38.0265.0
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒
72
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
STRONG
75
Valuation
FAIR
40
Growth
STEADY
63
Profitability
HIGH
95
Technicals
STRONG
70
Risk
LOW
90
Key Stats
TTM PE
38.02
P/B
22.64
52W HIGH
₹3120.7
OFF HIGH
-5.34%
DIV YIELD
2.48%
MKT CAP
₹50051 Cr
◉ Active Signals
MACDNeutral-12.8703
RSI(14)Neutral59.93
Street Consensus
4 analysts₹2969.75
mean target
Low ₹2600.0Now ₹2954.0High ₹3500.0
⧉ Strategy Fit 🔒